BioSpace News Archive

Pharm Country

Harmony Biosciences Opens Applications For 2022 Progress At The Heart Program

Harmony Biosciences Holdings, Inc. is now accepting applications for the second annual Progress at the Heart program, which funds innovative programs that address disparities, injustice, and inequities in the rare neurological disease and sleep disorder communities.

April 7, 2022
·
3 min read
Business

Seagen to Host Conference Call and Webcast Discussion of First Quarter 2022 Financial Results on April 28, 2022

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2022 financial results on Thursday, April 28, 2022 after the close of U.S. financial markets.

April 7, 2022
·
1 min read
Lone Star Bio

Saranas® Receives Innovative Technology Contract from Vizient

Saranas announced its Early Bird Bleed Monitoring System has received an Innovative Technology contract from Vizient, Inc., the nation’s largest member-driven health care performance improvement company.

April 7, 2022
·
3 min read
Genetown

Charles River Laboratories Publishes 2021 Corporate Citizenship Report

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2021 Corporate Citizenship Report.

April 7, 2022
·
4 min read
Genetown

Gamida Cell to Present Corporate Highlights and Participate in Panel Discussion at the Needham Healthcare Conference

Gamida Cell Ltd. announced that company management will present at the upcoming 21st Annual Needham Virtual Healthcare Conference on April 12, 2022 at 1:30 p.m. EDT.

April 7, 2022
·
4 min read
Pharm Country

Inspirna to Present at 21st Annual Needham Virtual Healthcare Conference

Inspirna, Inc. announced today that CEO Masoud Tavazoie, M.D., Ph.D., will present at the 21st Annual Needham Virtual Healthcare Conference at 10:15 A.M. EST on April 14, 2022.

April 7, 2022
·
1 min read
Genetown

Minerva Neurosciences Provides Update from Type C Meeting with FDA and Next Steps in Preparation for Submission of a New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

Minerva Neurosciences, Inc. announced today that it has received the official meeting minutes from the Type C meeting with the U.S. Food and Drug Administration (FDA) held on March 2, 2022, regarding development of roluperidone for the treatment of negative symptoms in schizophrenia.

April 7, 2022
·
11 min read
Deals

Integer Holdings Corporation Acquires Aran Biomedical

Integer Holdings Corporation announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical.

April 7, 2022
·
3 min read
Policy

Arterys Receives Its Eighth FDA Clearance Powered With AI and Releases Its Next-Generation Cardio AI Application

Arterys, the world’s leading vendor-neutral AI platform, has announced several new modules to its already robust Cardio AI clinical application and an additional FDA AI clearance based on deep learning.

April 7, 2022
·
3 min read
Business

DiaCarta Expands Board Leadership with Industry Veteran

DiaCarta Inc. announced the appointment of Jack Kaye, retired Partner with Deloitte LLP, as an independent board member who will serve as the Chairman of the Company’s Audit Committee.

April 7, 2022
·
3 min read